CUREMA
CuReMa is a consultancy firm that provides offer business-critical applications to SMB customers.
CUREMA
Industry:
Apps Consulting
Founded:
2007-08-19
Address:
Mechelen, Antwerpen, Belgium
Country:
Belgium
Website Url:
http://www.curema.be
Total Employee:
1+
Status:
Active
Contact:
32-473 51 40 32
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt Nginx Google Apps For Business Google Google Cloud QUIC
Official Site Inspections
http://www.curema.be
- Host name: 15.214.214.35.bc.googleusercontent.com
- IP address: 35.214.214.15
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "CuReMa"
Cureva
De naam Cureva komt voort uit de samenstelling van de woorden CURE (behandelen, herstellen/genezen) en REVA, wat staat voor revalidatie. Deze woorden hebben wij met elkaar …See details»
Contact – Cureva
Contacteer ons Lange Zandstraat 125, 2860 Sint-Katelijne-Waver +32 485 50 65 03 Grotenhof 7, 2640 Mortsel +32 479 82 12 92 [email protected] Facebook InstagramSee details»
About Us - CureVac
With a single discovery, CureVac opened the world up to the potential of mRNA to treat diseases and create vaccines. Officially founded in 2000, CureVac is the world’s first company to successfully harness mRNA for medical …See details»
Home - Curevo Vaccine
Curevo Vaccine is a clinical-stage biotech company dedicated to developing next-generation non-mRNA vaccines. We focus on one need at a time, allowing us to bring effective and better …See details»
CureVac
Driving medical progress From day one, people have always been central to CureVac’s mission — after all, we are on a mission to use therapeutic mRNA to transform people’s lives. That’s why we are dedicated to making CureVac a …See details»
About Us - Cureva HealthCare
Cureva HealthCare was founded with a vision to bridge the gap between quality healthcare and accessibility. Over the years, we have expanded our services, integrating advanced …See details»
Our Locations - CureVac
250 Summer St 3rd Fl Boston, MA 02210, USA P +1 617 377404 – 0See details»
CureVac - Wikipedia
Headquarters of CureVac in Tübingen CureVac N.V. is a German biopharmaceutical company. It develops therapies based on messenger RNA (mRNA). Headquartered in Tübingen, …See details»
CureVac - LinkedIn
CureVac (Nasdaq: CVAC) is a pioneering multinational biotech company founded in 2000 to advance the field of messenger RNA (mRNA) technology for application in human medicine. In …See details»
Home | Curiva 2024
Our flagship product, diaPatchâ„¢, is a novel microneedles patch that detects cervical cancer biomarkers. It has many distinct advantages over the Pap smear test. diaPatchâ„¢ is a triage tool at the interphase of the Pap smear and the …See details»
CureVac COVID-19 vaccine - Wikipedia
The CureVac COVID-19 vaccine (abbreviated CVnCoV) was a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness Innovations (CEPI). …See details»
COVID-19 - CureVac
The COVID-19 pandemic poses one of the greatest challenges humankind has faced this century. Developing a safe and effective vaccine to meet this challenge is the best way to save lives …See details»
GSK and CureVac announce strategic mRNA technology …
Jul 20, 2020 For media and investors only Issued: London UK; Tübingen, Germany/ Boston, MA, USA Companies to collaborate on mRNA vaccine and monoclonal antibody research …See details»
Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine …
May 31, 2023 Vaccines play an important role in maintaining human and animal health worldwide. There is continued demand for effective and safe adjuvants capable of enhancing …See details»
CureVac Strengthens Ongoing Patent Litigations Bringing …
Jul 13, 2023 CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid …See details»
Production - CureVac
CureVac is truly a one-stop shop for mRNA therapeutics, encompassing every step along the R&D journey, from discovery to production. Our high standards for discovery and production …See details»
CureVac Announces Positive Phase 2 Interim Data from COVID-19 …
Jan 5, 2024 Head-to-head comparison with licensed bivalent mRNA-based comparator vaccine confirms competitive immune responses at lower doses and favorable tolerability profile …See details»
CureVac launches 'RNA Printer' subsidiary to provide clients with ...
Mar 1, 2022 CureVac, a German biotech, formed a new subsidiary centered on the company’s RNA Printer technology that integrates and automates the manufacturing process for RNA …See details»
CureVac Receives U.S. Patent Covering Entire Process for …
Mar 22, 2018 CureVac AG, a fully-integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that the U.S. Patent and Trademark Office has issued …See details»
Tesla teams up with CureVac to make 'RNA microfactories' for …
Jul 2, 2020 German vaccine maker CureVac has lost some shine in the race for a COVID-19 shot after other mRNA-based hopefuls have captured regulators' attention.See details»